← Back to catalogue

Brella

FDA UDI

Class II (US FDA UDI)

by Candesant Biomedical, Inc.

Identity

Trade Name
Brella FDA UDI
Generic Name
Antiperspirant FDA UDI
Device Name
Ten count (CB-1067) a skin patch for the treatment of hyperhidrosis in a prescription topical patch that utilizes a chemical reaction to generate thermal energy in situ for treatment of hyperhidrosis FDA UDI
Model / Reference
CB-1050 FDA UDI
Description
Ten count (CB-1067) a skin patch for the treatment of hyperhidrosis in a prescription topical patch that utilizes a chemical reaction to generate thermal energy in situ for treatment of hyperhidrosis FDA UDI

Identifiers

Catalog Number
CB-1050 FDA UDI
Primary DI / UDI-DI
00860009462229 FDA UDI
FDA Product Code
QVX FDA UDI
GMDN Term
Antiperspirant FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.4425 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Antiperspirant

Brella by Candesant Biomedical, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Antiperspirant.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Candesant Biomedical, Inc.

Sources (1)

  • FDA UDI 0762458b-9885-42a1-9a44-2e07d09fd3c9 37 fields · synced Jun 8, 2026